體外診斷用醫藥品的全球市場 2022-2026
市場調查報告書
商品編碼
1144284

體外診斷用醫藥品的全球市場 2022-2026

Global In-vitro Diagnostics Market 2022-2026

出版日期: | 出版商: TechNavio | 英文 120 Pages | 訂單完成後即時交付

價格

體外診斷用醫藥品的市場規模在2022年~2026年間,預測將成長到331億6000萬美元,在預測期間內預計將以6.89%的年複合成長率增長。本報告提供體外診斷用醫藥品市場整體分析,市場規模與預測,趨勢,成長促進因素·課題,網羅了約25供應商的供應商分析等資訊。

同時本報告還提供當前全球市場趨勢與推動因素以及整體市場環境的最新分析。

市場成長的主要因素有老年人口的增加,慢性疾病和感染疾病,個人化醫療的高需求,藥物研發的投資增加。

目錄

第1章 摘要整理

  • 市場概要

第2章 市場形勢

  • 市場生態系統

第3章 市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模 2021
  • 市場預測:2021-2026年的預測

第4章 波特的五力分析

  • 五力的摘要
  • 買方議價能力
  • 供給企業談判力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 競爭的威脅
  • 市場情況

第5章 各科技的市場區隔

  • 市場明細
  • 各技術比較
  • 免疫測量 - 市場規模與預測 2021-2026
  • 分子診斷 - 市場規模與預測 2021-2026
  • 臨床化學 - 市場規模與預測 2021-2026
  • 血液學 - 市場規模與預測 2021-2026
  • 其他 - 市場規模與預測 2021-2026
  • 各科技的市場機會

第6章 客戶形勢

  • 客戶形勢概要

第7章 各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美 - 市場規模與預測 2021-2026
  • 歐洲 - 市場規模與預測 2021-2026
  • 亞洲 - 市場規模與預測 2021-2026
  • 其他地區(ROW) - 市場規模與預測 2021-2026
  • 美國 - 市場規模與預測 2021-2026
  • 中國 - 市場規模與預測 2021-2026
  • 日本 - 市場規模與預測 2021-2026
  • 德國 - 市場規模與預測 2021-2026
  • 加拿大 - 市場規模與預測 2021-2026
  • 各地區形勢的市場機會

第8章 促進因素,課題,及趨勢

  • 推動市場要素
  • 市場課題
  • 推動因素與課題的影響
  • 市場趨勢

第9章 業者情勢

  • 概要
  • 業者情勢
  • 混亂狀況
  • 產業的風險

第10章 供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Abbott Laboratories
  • Danaher Corp.
  • DiaSorin SpA
  • F. Hoffmann La Roche Ltd.
  • Illumina Inc.
  • Ortho Clinical Diagnostics plc
  • Quest Diagnostics Inc.
  • Siemens AG
  • Sysmex Corp
  • Thermo Fisher Scientific Inc.

第11章 附錄

Product Code: IRTNTR71317

Technavio has been monitoring the in-vitro diagnostics market and it is poised to grow by $ 33.16 bn during 2022-2026, accelerating at a CAGR of 6.89% during the forecast period. Our report on the in-vitro diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing geriatric population, chronic, and infectious diseases, high demand for personalized medicine, and increasing investments in drug discovery.

The in-vitro diagnostics market analysis includes the technology segment and geographic landscape.

Technavio's in-vitro diagnostics market is segmented as below:

By Technology

  • Immunoassay
  • Molecular diagnostics
  • Clinical chemistry
  • Hematology
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the technological advances in in-vitro diagnostics as one of the prime reasons driving the in-vitro diagnostics market growth during the next few years. Also, the global adoption of advanced treatment solutions and innovations in the digital in-vitro diagnostics sector will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the in-vitro diagnostics market covers the following areas:

  • In-vitro diagnostics market sizing
  • In-vitro diagnostics market forecast
  • In-vitro diagnostics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading in-vitro diagnostics market vendors that include Abbott Laboratories, Agilent Technologies Inc., ARKRAY Inc., Becton Dickinson, and Co., BGI Group, Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Grifols SA, Illumina Inc., Ortho Clinical Diagnostics plc, QIAGEN NV, Quest Diagnostics Inc., Siemens AG, Sysmex Corp, and Thermo Fisher Scientific Inc. Also, the in-vitro diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Technology
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Technology

  • 5.1 Market segments
  • Exhibit 24: Chart on Technology - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Technology - Market share 2021-2026 (%)
  • 5.2 Comparison by Technology
  • Exhibit 26: Chart on Comparison by Technology
  • Exhibit 27: Data Table on Comparison by Technology
  • 5.3 Immunoassay - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Immunoassay - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 29: Data Table on Immunoassay - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 30: Chart on Immunoassay - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Immunoassay - Year-over-year growth 2021-2026 (%)
  • 5.4 Molecular diagnostics - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Molecular diagnostics - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 33: Data Table on Molecular diagnostics - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 34: Chart on Molecular diagnostics - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Molecular diagnostics - Year-over-year growth 2021-2026 (%)
  • 5.5 Clinical chemistry - Market size and forecast 2021-2026
  • Exhibit 36: Chart on Clinical chemistry - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 37: Data Table on Clinical chemistry - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 38: Chart on Clinical chemistry - Year-over-year growth 2021-2026 (%)
  • Exhibit 39: Data Table on Clinical chemistry - Year-over-year growth 2021-2026 (%)
  • 5.6 Hematology - Market size and forecast 2021-2026
  • Exhibit 40: Chart on Hematology - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 41: Data Table on Hematology - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 42: Chart on Hematology - Year-over-year growth 2021-2026 (%)
  • Exhibit 43: Data Table on Hematology - Year-over-year growth 2021-2026 (%)
  • 5.7 Others - Market size and forecast 2021-2026
  • Exhibit 44: Chart on Others - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 45: Data Table on Others - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 46: Chart on Others - Year-over-year growth 2021-2026 (%)
  • Exhibit 47: Data Table on Others - Year-over-year growth 2021-2026 (%)
  • 5.8 Market opportunity by Technology
  • Exhibit 48: Market opportunity by Technology ($ billion)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 50: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 52: Chart on Geographic comparison
  • Exhibit 53: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 China - Market size and forecast 2021-2026
  • Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.9 Japan - Market size and forecast 2021-2026
  • Exhibit 78: Chart on Japan - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 79: Data Table on Japan - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 80: Chart on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibit 81: Data Table on Japan - Year-over-year growth 2021-2026 (%)
  • 7.10 Germany - Market size and forecast 2021-2026
  • Exhibit 82: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 83: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 84: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 85: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.11 Canada - Market size and forecast 2021-2026
  • Exhibit 86: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 87: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 88: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 89: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 90: Market opportunity By Geographical Landscape ($ billion)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 91: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 93: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 94: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 95: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 96: Matrix on vendor position and classification
  • 10.3 Abbott Laboratories
  • Exhibit 97: Abbott Laboratories - Overview
  • Exhibit 98: Abbott Laboratories - Business segments
  • Exhibit 99: Abbott Laboratories - Key news
  • Exhibit 100: Abbott Laboratories - Key offerings
  • Exhibit 101: Abbott Laboratories - Segment focus
  • 10.4 Danaher Corp.
  • Exhibit 102: Danaher Corp. - Overview
  • Exhibit 103: Danaher Corp. - Business segments
  • Exhibit 104: Danaher Corp. - Key news
  • Exhibit 105: Danaher Corp. - Key offerings
  • Exhibit 106: Danaher Corp. - Segment focus
  • 10.5 DiaSorin SpA
  • Exhibit 107: DiaSorin SpA - Overview
  • Exhibit 108: DiaSorin SpA - Business segments
  • Exhibit 109: DiaSorin SpA - Key news
  • Exhibit 110: DiaSorin SpA - Key offerings
  • Exhibit 111: DiaSorin SpA - Segment focus
  • 10.6 F. Hoffmann La Roche Ltd.
  • Exhibit 112: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 113: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 114: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 115: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 116: F. Hoffmann La Roche Ltd. - Segment focus
  • 10.7 Illumina Inc.
  • Exhibit 117: Illumina Inc. - Overview
  • Exhibit 118: Illumina Inc. - Business segments
  • Exhibit 119: Illumina Inc. - Key news
  • Exhibit 120: Illumina Inc. - Key offerings
  • Exhibit 121: Illumina Inc. - Segment focus
  • 10.8 Ortho Clinical Diagnostics plc
  • Exhibit 122: Ortho Clinical Diagnostics plc - Overview
  • Exhibit 123: Ortho Clinical Diagnostics plc - Business segments
  • Exhibit 124: Ortho Clinical Diagnostics plc - Key offerings
  • Exhibit 125: Ortho Clinical Diagnostics plc - Segment focus
  • 10.9 Quest Diagnostics Inc.
  • Exhibit 126: Quest Diagnostics Inc. - Overview
  • Exhibit 127: Quest Diagnostics Inc. - Business segments
  • Exhibit 128: Quest Diagnostics Inc. - Key offerings
  • Exhibit 129: Quest Diagnostics Inc. - Segment focus
  • 10.10 Siemens AG
  • Exhibit 130: Siemens AG - Overview
  • Exhibit 131: Siemens AG - Business segments
  • Exhibit 132: Siemens AG - Key news
  • Exhibit 133: Siemens AG - Key offerings
  • Exhibit 134: Siemens AG - Segment focus
  • 10.11 Sysmex Corp
  • Exhibit 135: Sysmex Corp - Overview
  • Exhibit 136: Sysmex Corp - Business segments
  • Exhibit 137: Sysmex Corp - Key offerings
  • Exhibit 138: Sysmex Corp - Segment focus
  • 10.12 Thermo Fisher Scientific Inc.
  • Exhibit 139: Thermo Fisher Scientific Inc. - Overview
  • Exhibit 140: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 141: Thermo Fisher Scientific Inc. - Key news
  • Exhibit 142: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 143: Thermo Fisher Scientific Inc. - Segment focus

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 144: Inclusions checklist
  • Exhibit 145: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 146: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 147: Research methodology
  • Exhibit 148: Validation techniques employed for market sizing
  • Exhibit 149: Information sources
  • 11.5 List of abbreviations
  • Exhibit 150: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Technology
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Technology - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Technology - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Technology
  • Exhibits27: Data Table on Comparison by Technology
  • Exhibits28: Chart on Immunoassay - Market size and forecast 2021-2026 ($ billion)
  • Exhibits29: Data Table on Immunoassay - Market size and forecast 2021-2026 ($ billion)
  • Exhibits30: Chart on Immunoassay - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Immunoassay - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Molecular diagnostics - Market size and forecast 2021-2026 ($ billion)
  • Exhibits33: Data Table on Molecular diagnostics - Market size and forecast 2021-2026 ($ billion)
  • Exhibits34: Chart on Molecular diagnostics - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Molecular diagnostics - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Chart on Clinical chemistry - Market size and forecast 2021-2026 ($ billion)
  • Exhibits37: Data Table on Clinical chemistry - Market size and forecast 2021-2026 ($ billion)
  • Exhibits38: Chart on Clinical chemistry - Year-over-year growth 2021-2026 (%)
  • Exhibits39: Data Table on Clinical chemistry - Year-over-year growth 2021-2026 (%)
  • Exhibits40: Chart on Hematology - Market size and forecast 2021-2026 ($ billion)
  • Exhibits41: Data Table on Hematology - Market size and forecast 2021-2026 ($ billion)
  • Exhibits42: Chart on Hematology - Year-over-year growth 2021-2026 (%)
  • Exhibits43: Data Table on Hematology - Year-over-year growth 2021-2026 (%)
  • Exhibits44: Chart on Others - Market size and forecast 2021-2026 ($ billion)
  • Exhibits45: Data Table on Others - Market size and forecast 2021-2026 ($ billion)
  • Exhibits46: Chart on Others - Year-over-year growth 2021-2026 (%)
  • Exhibits47: Data Table on Others - Year-over-year growth 2021-2026 (%)
  • Exhibits48: Market opportunity by Technology ($ billion)
  • Exhibits49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits50: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits52: Chart on Geographic comparison
  • Exhibits53: Data Table on Geographic comparison
  • Exhibits54: Chart on North America - Market size and forecast 2021-2026 ($ billion)
  • Exhibits55: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
  • Exhibits56: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
  • Exhibits59: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
  • Exhibits60: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
  • Exhibits63: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
  • Exhibits64: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
  • Exhibits67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
  • Exhibits68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on US - Market size and forecast 2021-2026 ($ billion)
  • Exhibits71: Data Table on US - Market size and forecast 2021-2026 ($ billion)
  • Exhibits72: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on China - Market size and forecast 2021-2026 ($ billion)
  • Exhibits75: Data Table on China - Market size and forecast 2021-2026 ($ billion)
  • Exhibits76: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Chart on Japan - Market size and forecast 2021-2026 ($ billion)
  • Exhibits79: Data Table on Japan - Market size and forecast 2021-2026 ($ billion)
  • Exhibits80: Chart on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibits81: Data Table on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibits82: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
  • Exhibits83: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
  • Exhibits84: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits85: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits86: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
  • Exhibits87: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
  • Exhibits88: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits89: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits90: Market opportunity By Geographical Landscape ($ billion)
  • Exhibits91: Impact of drivers and challenges in 2021 and 2026
  • Exhibits92: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits93: Overview on factors of disruption
  • Exhibits94: Impact of key risks on business
  • Exhibits95: Vendors covered
  • Exhibits96: Matrix on vendor position and classification
  • Exhibits97: Abbott Laboratories - Overview
  • Exhibits98: Abbott Laboratories - Business segments
  • Exhibits99: Abbott Laboratories - Key news
  • Exhibits100: Abbott Laboratories - Key offerings
  • Exhibits101: Abbott Laboratories - Segment focus
  • Exhibits102: Danaher Corp. - Overview
  • Exhibits103: Danaher Corp. - Business segments
  • Exhibits104: Danaher Corp. - Key news
  • Exhibits105: Danaher Corp. - Key offerings
  • Exhibits106: Danaher Corp. - Segment focus
  • Exhibits107: DiaSorin SpA - Overview
  • Exhibits108: DiaSorin SpA - Business segments
  • Exhibits109: DiaSorin SpA - Key news
  • Exhibits110: DiaSorin SpA - Key offerings
  • Exhibits111: DiaSorin SpA - Segment focus
  • Exhibits112: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits113: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits114: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits115: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits116: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits117: Illumina Inc. - Overview
  • Exhibits118: Illumina Inc. - Business segments
  • Exhibits119: Illumina Inc. - Key news
  • Exhibits120: Illumina Inc. - Key offerings
  • Exhibits121: Illumina Inc. - Segment focus
  • Exhibits122: Ortho Clinical Diagnostics plc - Overview
  • Exhibits123: Ortho Clinical Diagnostics plc - Business segments
  • Exhibits124: Ortho Clinical Diagnostics plc - Key offerings
  • Exhibits125: Ortho Clinical Diagnostics plc - Segment focus
  • Exhibits126: Quest Diagnostics Inc. - Overview
  • Exhibits127: Quest Diagnostics Inc. - Business segments
  • Exhibits128: Quest Diagnostics Inc. - Key offerings
  • Exhibits129: Quest Diagnostics Inc. - Segment focus
  • Exhibits130: Siemens AG - Overview
  • Exhibits131: Siemens AG - Business segments
  • Exhibits132: Siemens AG - Key news
  • Exhibits133: Siemens AG - Key offerings
  • Exhibits134: Siemens AG - Segment focus
  • Exhibits135: Sysmex Corp - Overview
  • Exhibits136: Sysmex Corp - Business segments
  • Exhibits137: Sysmex Corp - Key offerings
  • Exhibits138: Sysmex Corp - Segment focus
  • Exhibits139: Thermo Fisher Scientific Inc. - Overview
  • Exhibits140: Thermo Fisher Scientific Inc. - Business segments
  • Exhibits141: Thermo Fisher Scientific Inc. - Key news
  • Exhibits142: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibits143: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibits144: Inclusions checklist
  • Exhibits145: Exclusions checklist
  • Exhibits146: Currency conversion rates for US$
  • Exhibits147: Research methodology
  • Exhibits148: Validation techniques employed for market sizing
  • Exhibits149: Information sources
  • Exhibits150: List of abbreviations